RecruitingPhase 3NCT07174310
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Sponsor: Hoffmann-La Roche
Fullerton, CA · La Jolla, CA · Los Angeles, CA · +50 more sites
1 recruiting parkinson's disease studies with a site in Pasadena, CA.
Sponsor: Hoffmann-La Roche
Fullerton, CA · La Jolla, CA · Los Angeles, CA · +50 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.